Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Max Healthcare InstituteNSE:MAXHEALTH +1.19%93 5-Year Yield-on-Cost % is 0.20 as of Sep. 21, 2026, which is 43% above its 10-year median of 0.14. GuruFocus rates NSE:MAXHEALTH with a GF Score™ of 93/100 and a GF Value™ of ₹1,480.50 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 281 Healthcare Providers & Services companies, Max Healthcare Institute ranks worse than 96.44% on this metric.
The historical rank and industry rank for Max Healthcare Institute's 5-Year Yield-on-Cost % or its related term are showing as below:
NSE:MAXHEALTH'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.09 Med: 0.14 Max: 0.27
Current: 0.2
During the past 11 years, Max Healthcare Institute's highest Yield on Cost was 0.27. The lowest was 0.09. And the median was 0.14.
NSE:MAXHEALTH's 5-Year Yield-on-Cost % is ranked worse than 96.44% of 281
companies
in the Healthcare Providers & Services industry
Industry Median: 2.99
vs NSE:MAXHEALTH: 0.20
Max Healthcare Institute (NSE:MAXHEALTH) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Max Healthcare Institute 5-Year Yield-on-Cost % Related Terms
NSE:MAXHEALTH vs HCA, THC, EHC: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Max Healthcare Institute's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Max Healthcare Institute 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Max Healthcare Institute's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Max Healthcare Institute's 5-Year Yield-on-Cost % falls into.
Max Healthcare Institute 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Max Healthcare Institute (NSE:MAXHEALTH) has a 5-Year Yield-on-Cost % of 0.20 as of Sep. 21, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Max Healthcare Institute and its competitors. This is 43% above median its historical median of 0.14. Over the past decade, Max Healthcare Institute's 5-Year Yield-on-Cost % has ranged from 0.09 to 0.27. According to the industry distribution chart, Max Healthcare Institute ranks #271 out of 281 companies in the Healthcare Providers & Services industry, placing it in the top 96.4%.
Is Max Healthcare Institute's 5-Year Yield-on-Cost % too high?
Max Healthcare Institute's current 5-Year Yield-on-Cost % of 0.20 is 43% above median its 10-year median of 0.14. Over the past 10 years, this metric has ranged from a low of 0.09 to a high of 0.27. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.99. Max Healthcare Institute's value of 0.20 is 93.3% below this industry median. Based on the distribution chart, Max Healthcare Institute ranks #271 out of 281 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Max Healthcare Institute has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Max Healthcare Institute's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Max Healthcare Institute ranks #271 out of 281 companies for 5-Year Yield-on-Cost %. This places Max Healthcare Institute in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.99. Max Healthcare Institute's value of 0.20 is 93.3% below this benchmark. Historically, Max Healthcare Institute's own 5-Year Yield-on-Cost % has ranged from 0.09 to 0.27 over the past decade. While the company's 10-year median is 0.14 vs. the industry median of 2.99, Max Healthcare Institute has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.99, based on 281 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Max Healthcare Institute's current 5-Year Yield-on-Cost % of 0.20 is 93.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Max Healthcare Institute and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Max Healthcare Institute's current 5-Year Yield-on-Cost % is 0.20, which is 43% above median its own 10-year median of 0.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Max Healthcare Institute stock overvalued right now?
Based on GuruFocus' analysis, Max Healthcare Institute (NSE:MAXHEALTH) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,480.50, compared to a current price of ₹1,049.30 — trading 29.1% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.20, which is 43% above median its 10-year median of 0.14 and 93.3% below the Healthcare Providers & Services industry median of 2.99. Max Healthcare Institute's overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Max Healthcare Institute (NSE:MAXHEALTH), the current 5-Year Yield-on-Cost % is 0.20 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Max Healthcare Institute (NSE:MAXHEALTH) Overvalued in 2026?
Based on GuruFocus' analysis, Max Healthcare Institute stock appears to be undervalued.
The current stock price of ₹1,049.30 is trading 29.1% below its estimated GF Value™ of ₹1,480.50.
GuruFocus considers Max Healthcare Institute to be Modestly Undervalued.
Key valuation signals for NSE:MAXHEALTH:
5-Year Yield-on-Cost %: 0.20 (43% above median its 10-year median of 0.14)
GF Value™: ₹1,480.50 vs. price of ₹1,049.30 (29.1% below fair value)
Industry Position: 93.3% below the Healthcare Providers & Services median (#271 of 281)
No single metric tells the full story. See the NSE:MAXHEALTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Max Healthcare Institute Ltd is a health care service provider. The company's facilities include third-party healthcare providers with whom the company has entered long-term service contracts for providing clinical, radiology, and pathology services. Its hospitals provide the full range of services through its Outpatient, Day Care, Emergency Room, and In-Patient departments to accommodate medical specialties such as orthopedics, internal medicine, general surgery, cardiac sciences, oncology, neurosciences, and obstetrics, as well as diagnostics. The group derives revenue from India.
93GF Score
Get the complete analysis for NSE:MAXHEALTH
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MAXHEALTH has been successfully added to your 
